With 40% ownership, Entrada Therapeutics, Inc. (NASDAQ:TRDA) has piqued the interest of institutional investors

By Yahoo! Finance | Jun 27, 2024 at 07:34 AM EST

Five investors collectively own a majority stake of 55% in Entrada Therapeutics, Inc. Institutions hold the largest share at 40%, followed by hedge funds and insiders. This ownership structure influences company decisions and performance.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.